Mostrar el registro sencillo del ítem
dc.contributor.author | Herrera Gómez, Francisco Magno | |
dc.contributor.author | Gutiérrez Abejón, Eduardo | |
dc.contributor.author | García Mingo, Mercedes | |
dc.contributor.author | Álvarez González, Francisco Javier | |
dc.date.accessioned | 2023-06-05T08:13:01Z | |
dc.date.available | 2023-06-05T08:13:01Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | International Journal of Environmental Research and Public Health, 2021, Vol. 18, Nº. 10, 5371 | es |
dc.identifier.issn | 1660-4601 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/59726 | |
dc.description | Producción Científica | es |
dc.description.abstract | We are using real-life data in order to determine the prevalence of driving with the presence of cocaine and/or benzoylecgonine (BZE), their concentrations, and their use in combination with other drugs. This study assessed data on Spanish drivers with confirmed drug-positive results recorded by the Spanish National Traffic Agency from 2011–2016. Frequencies of positivity for cocaine and/or BZE and concentration of such substances were obtained. Comparisons and univariate and multivariate regression analyses were performed. Drivers who tested positive for cocaine and/or BZE accounted for 48.59% of the total positive results for drugs. In positive cases for both cocaine and BZE, other substances were detected in 81.74%: delta-9-tetrahydrocannabinol (THC) (68.19%), opioids (20.78%) and amphetamine-like substances (16.76%). In the multivariate logistic regression analysis, the frequency of cocaine and/or BZE positive cases decreased with age (OR:0.97) and were less likely among women (OR:0.63). Concentrations (ng/mL) of cocaine (249.30) and BZE (137.90) were higher when both substances were detected together than when detected alone. Positivity to cocaine represented an important proportion among Spanish drivers who tested positive for drugs, and polysubstance use was especially observed in more than 8 out of 10 positive cases for cocaine and/or BZE. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Automobile driving | es |
dc.subject | Automóviles - Conducción | es |
dc.subject | Drunk driving - Spain | es |
dc.subject | Cocaine - Toxicology | es |
dc.subject | Saliva | es |
dc.subject | Psychotropic drugs | es |
dc.subject | Abuso de substancias | es |
dc.subject | Drugs of abuse - Analysis | es |
dc.subject | Pharmacology | |
dc.subject | Toxicology | |
dc.title | Positivity to cocaine and/or benzoylecgonine in confirmation analyses for on-road tests in Spain | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © 2021 The authors | es |
dc.identifier.doi | 10.3390/ijerph18105371 | es |
dc.relation.publisherversion | https://www.mdpi.com/1660-4601/18/10/5371 | es |
dc.identifier.publicationfirstpage | 5371 | es |
dc.identifier.publicationissue | 10 | es |
dc.identifier.publicationtitle | International Journal of Environmental Research and Public Health | es |
dc.identifier.publicationvolume | 18 | es |
dc.peerreviewed | SI | es |
dc.description.project | Instituto de Salud Carlos III y Fondo Europeo de Desarrollo Regional (FEDER) - (RD16/0017/0006) | es |
dc.identifier.essn | 1660-4601 | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
dc.subject.unesco | 3214 Toxicología | es |
dc.subject.unesco | 3209 Farmacología |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Atribución 4.0 Internacional